Personal的問題，透過圖書和論文來找解法和答案更準確安心。 我們找到下列包括賽程、直播線上看和比分戰績懶人包

When the Truth Finds the Light: Finding the Courage to Keep Showing Up

為了解決Personal的問題，作者Doby, Danielle 這樣論述：

In this unique offering, The Unbound Body explores author Danielle Doby’s deeply personal journey with cancer through both poetry and memoir. Doby offers her insights on grief, joy, trauma, love, healing, and how one can move closer to life by choosing to offer their attention, staying present in

moment and body.At the young age of 34, and having spent three years traveling through the medical system in search of answers, Danielle Doby was given the news that she had an aggressive form of breast cancer. Everything she held to be true was thrown out of her grasp and scattered across the floo

r, down at her feet. What she didn’t know then, that she soon learned, a global pandemic was nearing, and much of the unknown that lay before her would need to be traveled alone. Doby’s intimate way of storytelling strives to answer the questions, What defines a miracle? And, when do you know you’v

e experienced one?

Personal進入發燒排行的影片

使用理財機器人的行為意圖之研究

為了解決Personal的問題，作者林昱德 這樣論述：

本研究以探討使用者使用理財機器人之使用行為相關研究，目的為探討使用者使用因素，提供未來後續業界之參考，以及找出現階段理財機器人使用者的描述性統計分析。本研究以有使用過銀行推出之理財機器人作為研究對象，於 2022年 7月 14日於網路進行正式問卷投放，回收後進行資料分析，經過問卷後台揭露，本次問卷研究投放人數為 4765 人，回收 490 份問卷，有效得 387份，有效回收率為 78.79%。研究架構以 UTAUT2 為基礎，並加入感知風險成為新的會影響使用意圖的因素。研究結果顯示，績效預期、社群影響、促進條件、價格價值以及習慣會對行為意圖產生顯著正向影響；努力預期以及感知風險對行為意圖則是

沒有影響；行為意圖以及習慣對使用行為有顯著正向影響；促進條件對使用意圖則無影響。希冀本研究可以作為相關單位的參考依據。

Adventures in Feminist Dramaturgy: The Road Less Traveled

為了解決Personal的問題，作者Hope, Laura Lee/ Kelly, Philippa 這樣論述：

In their lively invocation of a feminist dramaturgy that can lead to innovative and challenging directions in modern theatre-making, Laura Hope and Philippa Kelly make use of first-hand interviews with directors, actors, designers, and critics, as well as their own experiences in the theatre, to ope

n up feminist dramaturgy as a field of enquiry and performance possibility. The authors begin by discussing what happens when a dramaturg's performance strategies are vastly different from what a director envisions. This discussion moves naturally to Hope and Kelly's analysis of canonical plays they

hope to re-think in terms of gender at the same time that they resist the implication that a feminist perspective is a prescription for a political and social agenda. Casting a critical eye on "mainstream" approaches to classical plays, the authors revisit casting practices, editing philosophies, a

nd directorial concepts that provide thin, stereotypical depictions of male and female characters, arguing for closer textual and cultural analyses of misguided ventures such as the Lysistrata Project. Their commentary on appeals to audience involvement highlights the difficulty of challenging audie

nce preconceptions and the possibilities for expanding audience reception, while the counterproductive rigidity with which organizations like the Beckett estate resist new approaches to theatrical production are exposed in a discussion of feminist dramaturgy's potential to reinvigorate a play like W

aiting for Godot. Adventures in Dramaturgy concludes with the authors' personal journey to forge new directions within a specific theatre company and in the professional world at large. Laura Hope is Assistant Professor of Theatre at Loyola University New Orleans and Philippa Kelly is Resident Dra

maturg at the California Shakespeare Theater, USA.

An Integrated Approach For Uncovering Novel DNA Methylation Biomarkers For Non-small Cell Lung Carcinoma

為了解決Personal的問題，作者VAIBHAV KUMAR SUNKARIA 這樣論述：

Introduction - Lung cancer is one of primal and ubiquitous cause of cancer related fatalities in the world. Leading cause of these fatalities is non-small cell lung cancer (NSCLC) with a proportion of 85%. The major subtypes of NSCLC are Lung Adenocarcinoma (LUAD) and Lung Small Cell Carcinoma (LUS

C). Early-stage surgical detection and removal of tumor offers a favorable prognosis and better survival rates. However, a major portion of 75% subjects have stage III/IV at the time of diagnosis and despite advanced major developments in oncology survival rates remain poor. Carcinogens produce wide

spread DNA methylation changes within cells. These changes are characterized by globally hyper or hypo methylated regions around CpG islands, many of these changes occur early in tumorigenesis and are highly prevalent across a tumor type.Structure - This research work took advantage of publicly avai

lable methylation profiling resources and relevant comorbidities for lung cancer patients extracted from meta-analysis of scientific review and journal available at PubMed and CNKI search which were combined systematically to explore effective DNA methylation markers for NSCLC. We also tried to iden

tify common CpG loci between Caucasian, Black and Asian racial groups for identifying ubiquitous candidate genes thoroughly. Statistical analysis and GO ontology were also conducted to explore associated novel biomarkers. These novel findings could facilitate design of accurate diagnostic panel for

practical clinical relevance.Methodology - DNA methylation profiles were extracted from TCGA for 418 LUAD and 370 LUSC tissue samples from patients compared with 32 and 42 non-malignant ones respectively. Standard pipeline was conducted to discover significant differentially methylated sites as prim

ary biomarkers. Secondary biomarkers were extracted by incorporating genes associated with comorbidities from meta-analysis of research articles. Concordant candidates were utilized for NSCLC relevant biomarker candidates. Gene ontology annotations were used to calculate gene-pair distance matrix fo

r all candidate biomarkers. Clustering algorithms were utilized to categorize candidate genes into different functional groups using the gene distance matrix. There were 35 CpG loci identified by comparing TCGA training cohort with GEO testing cohort from these functional groups, and 4 gene-based pa

nel was devised after finding highly discriminatory diagnostic panel through combinatorial validation of each functional cluster.Results – To evaluate the gene panel for NSCLC, the methylation levels of SCT(Secritin), FOXD3(Forkhead Box D3), TRIM58(Tripartite Motif Containing 58) and TAC1(Tachikinin

1) were tested. Individually each gene showed significant methylation difference between LUAD and LUSC training cohort. Combined 4-gene panel AUC, sensitivity/specificity were evaluated with 0.9596, 90.43%/100% in LUAD; 0.949, 86.95%/98.21% in LUSC TCGA training cohort; 0.94, 85.92%/97.37 in GEO 66

836; 0.91,89.17%/100% in GEO 83842 smokers; 0.948, 91.67%/100% in GEO83842 non-smokers independent testing cohort. Our study validates SCT, FOXD3, TRIM58 and TAC1 based gene panel has great potential in early recognition of NSCLC undetermined lung nodules. The findings can yield universally accurate

and robust markers facilitating early diagnosis and rapid severity examination.